Prevalence of GBV-C and Its Impacts among Patients with Hepatitis B and C Viruses in Addis Ababa, Ethiopia

Mohamed Farouk^1, , Abate Bane Shewaye², Desta Kassa³ and Mekuria Lakew¹

¹Department of Microbial Cellular & Molecular Biology, Addis Ababa University, Addis Ababa, Ethiopia

²Schools of Medicine, Addis Ababa University, Addis Ababa, Ethiopia

³Infectious and Non-infectious Diseases Research Directorate, Ethiopian Health & Nutrition Research

Cite this paper:
Mohamed Farouk, Abate Bane Shewaye, Desta Kassa and Mekuria Lakew. Prevalence of GBV-C and Its Impacts among Patients with Hepatitis B and C Viruses in Addis Ababa, Ethiopia. American Journal of Microbiological Research. 2017; 5(1):1-6. doi: 10.12691/ajmr-5-1-1

Abstract

Background: Hepatocellular carcinoma (HCC) caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) is currently one of the most common neoplasms worldwide. GB virus C/hepatitis G virus (HGV/GBV-C) is a virus in the Flaviviridae family isolated from patients with liver disease. It has the same mode of transmission with HBV and HCV and is common in high risk group. The impact of HGV/GBV-C in clinical outcome among HBV and HCV is controversy. Therefore, this study was conducted to determine the prevalence and the association of (HGV/GBV-C) in the clinical outcome among HCV and HBV patients. Materials: This case-control study was performed in Addis Ababa University, Ethiopia. The cases were 101 patients with viral hepatitis collected from Adera internal medical specialty center. The control group consisted of 50 healthy individuals collected from the Ethiopian Public Health and Research Institutes. The serological analysis and liver enzyme levels were determined for each of the participants. RNA was extracted, reversed transcribed, and amplified by Real Time polymerase chain reaction (PCR), using primers for 5- untranslated region (5-UTR) of the GBV-C. Results: Analysis of the 101 samples of the hepatitis patients showed that; 83(82.2%) were positive for HBV while only18 (17.8%) for HCV. The prevalence of (HGV/GBV-C) RNA was 11(13.2%) in HBV, 2 (11.1%) in HCV and rests of the control group were negative. There was no significant difference (P > 0.05) in the liver enzymes level among (HGV/GBV-C) negative and positive individuals. Conclusion: Our study showed that the co-infection rate of (HGV/GBV-C) RNA among hepatitis patients was significantly higher (P <0.05) in HBV than in HCV patients, and the virus has no association in the course of the disease.

Keywords:
HGV/GBV-C HBV HCV RNA PCR

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Hu DJ, Bower WA, Ward JW. Viral hepatitis. In: Morse S, Moreland AA, Holmes KK, eds. Atlas of sexually transmitted diseases and AIDS. London: Elsevier; 2010: 203-29.
[2]	CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47.
[3]	Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-4.
[4]	Peters MG. Special populations with hepatitis B virus infection. Hepatology 2009; 49(Suppl 5): S146-S155.
[5]	Koopmans M., Duizer E. (2004): Foodborne viruses: an emerging problem. International Journal of Food Microbiology, 90, 23-41.
[6]	Vasickova P., Dvorska L., Lorencova A., Pavlik I. (2005): Viruses as a cause of foodborne diseases: a review of the literature. Veterinarni Medicina 50, 89-104.
[7]	Ashbolt N.J. (2004): Microbial contamination of drinking water and disease outcomes in developing regions. Toxicology, 198, 229-238.
[8]	Global policy report on the prevention and control of viral hepatitis (2013).World Health organization; Geneva, Switzerland.
[9]	Nassal M.HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 2015; 64: 1972-84.
[10]	Penin F. structural biology of hepatitis C virus. Clin Liver Dis 2003; 7: 1-21.
[11]	Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 2011; 92: 233-46.
[12]	Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004; 11(2): 97-107.
[13]	Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003; 23: 47-58.
[14]	McMahon BJ. The natural history of chronic hepatitis B virus infection. Semin Liver Dis 2004; 24: 17-21.
[15]	World Health Organization. Hepatitis C Fact Sheet N°164. Available from: Http: //www. who. int/ mediacentre /factsheets /fs164/en/. Last accessed: March 2016.
[16]	Sultan MT, Rahman MM, Begum S. Epidemiology of hepatitis C virus (HCV) infection. J Bangladesh Coll Phy Surg. 2009; 27: 160-2.
[17]	Lee MH, Yang HI, Yuan Y, Lltalien G, Chen CJ (2014). Epidemiology and natural history of hepatitis C virus infection. World J. Gastroenterol. 20(28): 9270-9280.
[18]	Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011;17: 107-115
[19]	Simons, J. N., T. P. Leary, G. J. Dawson, T. J. Pilot-Matias, A. S. Muerhoff, G. G. Schlauder, S. M. Desai, and I. K. Mushahwar. 1995a. Isolation of novelvirus-like sequences associated with human hepatitis. Nat Med 1: 564-569.
[20]	Linnen, J., J. Wages, Jr., Z. Y. Zhang-Keck, K. E. Fry, K. Z. Krawczynski, H. Alter, E. Koonin, M. Gallagher, M. Alter, S. Hadziyannis, P. Karayiannis, K. Fung, Y. Nakatsuji, J. W. Shih, L. Young, M. Piatak, Jr., C. Hoover, J. Fernandez, S. Chen, J. C. Zou, T. Morris, K. C. Hyams, S. Ismay, J. D. Lifson, G. Hess, S. K. Foung, H. Thomas, D. Bradley, H. Margolis, and J. P. Kim. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505-508.
[21]	Leary, T. P., A. S. Muerhoff, J. N. Simons, T. J. Pilot-Matias, J. C. Erker, M. L. Chalmers, G. G. Schlauder, G. J. Dawson, S. M. Desai, and I. K. Mushahwar. 1996. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 48: 60-67.
[22]	Cheung RC, Keeffe EB, and Greenberg HB, Hepatitis G virus: Is it a hepatitis virus? West J Med 167: 23-33. 1997.
[23]	Pavesi A, Detection of signature sequences in overlapping genes and prediction of a novel overlapping gene in hepatitis G virus. J Mol Evol 50: 284-295. 2000
[24]	Feng Y, Zhao W, Dai J, Li Z, Zhang X, Liu L, Bai J, Zhang H, Lu L, and Xia X, A novel genotype of GB virus C: its identification and predominance among injecting drug users in Yunnan, China, PLoS One 6: e21151. 2011.
[25]	Sathar MA, York DF, Group 5: GBV-C/HGV isolates from South Africa, J Med Virol 65: 121-122. 2011.
[26]	Scallan MF, Clutterbuck D, Jarvis LM, et al., Sexual transmission of GB virus C/hepatitis G virus, J Med Virol, 1998; 55: 203-8.
[27]	Nerurkar VR, Chua PK, Hoffmann PR, et al., High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission, J Med Virol, 1998; 56: 123-7.
[28]	Fischler B, Lara C, Chen M, et al., Genetic evidence for mother-to-infant transmission of hepatitis G virus, J Infect Dis, 1997; 176: 281-5.
[29]	Dawson,G.J. et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med V irol 50, 97-103 (1996).
[30]	Liu,H.F., Muyembe-Tamfum,J.J., Dahan,K., Desmyter,J. & Goubau,P. High prevalence of GB virus C/hepatitis G virus in Kinshasa. J Med Virol 60, 159-165 (2000).
[31]	Tucker,T.J., Louw,S.J., Robson,S.C., Isaacs,S. & Kirsch,R.E. High prevalence of GBV-C hepatitis G virus infection in a rural South African population. J Med Virol 53, 225-228 (1997).
[32]	Bhattarai N, Stapleton JT, GB virus C: the good boy virus? Trends Microbiol, 20(3): 124-30. 2012.
[33]	Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, and Saito H, Effect of GB virus C/hepatitis G virus co-infection on the course of HIV infection in hemophilia patients in Japan. Journal Acquired Immune Deficiency Syndromes.17: 209-13. 1998.
[34]	Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, Hunt J, Jou C, Solomon N, Schmidt RE, and Manns MP, GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? Journal of Infectious Diseases.177: 1723-6. 1998.
[35]	Bjorkman P, Flamholc L, Molnegren V, Marshall A, Guner N, Widell A (2007). Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART. AIDS. 21(12): 1641-1643.
[36]	Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unkown etiology. Lancet 1995; 346: 1131-2.
[37]	Alter J. A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37: 569-72.
[38]	Chams V, Fournier-Wirth C, Chabanel A, et al. Is GB virus-C alias “hepatitis G” involved in human pathology. Trans Clin Bioi 2003; 10: 292 306.
[39]	Birgit Kallinowski, Christine Buhrmann, Stefanie Seipp, Tobias Goeser, Wolfgang Stremmel, Gerd Otto, and Lorenz Theilmann (1998). Incidence, Prevalence, and Clinical Outcome of Hepatitis GB-C Virus Infection in Liver Transplant Patients. Liver Transplantation and Surgery, (4)1: 28-33.
[40]	Yue Feng, Li Liu, Yue-Mei Feng, Wenhua Zhao, Zheng Li, A-Mei Zhang, Yuzhu Song, and Xueshan Xia (2014). GB Virus C infection in Patients With HIV/Hepatitis C Virus Coinfection: Improvement of the Liver Function in Chronic Hepatitis C. Hepat Mon. 14(3): e14169.
[41]	Berg T, Naumann U, Fukumoto T, Lobeck W, Bechstein P, Neuhaus P, et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996;62: 711-714
[42]	Alvarado-Mora MV, Botelho L, Nishiya A, Neto RA, Gomes-Gouvea MS, Gutierrez MF, Carrilho FJ, Pinho JR (2011) Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection. Virol J 8: 345.
[43]	Tanaka E, Alter HJ, Nakatsuji Y, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med. 1996; 125(9): 740-3.
[44]	Ruiz V, Espinola L, Mathet VL, Perandones CE and Oubina JR, Design, development and evaluation of a competitive RT-PCR for quantitation of GBV-C RNA, J Virol Methods, 2006; 136: 58-64.
[45]	Thomas DL, Vlahov D, Alter HI, Hunt, Marshall R, Astemborski I and Nelson KE. (1998) Association of antibody to GB Virus C (Hepatitis G Virus) with viral clearance and protection from reinfection. J. Infect. Dis. 177, 539-542.
[46]	Masaru Enomoto, Shuhei,Shiguchi, Katsuhiko Fukuda, Tetsuo Kuroki, Motoharu Tanaka, Shuzo Otani, Masayuki Ogami, and Takeyuki Monna (1998). Characteristics of Patients with Hepatitis C Virus With and Without GB Virus C/Hepatitis G Virus Co-infection and Efficacy of Interferon Alfa. HEPATOLOGY, (27)5.
[47]	Tanaka Y, Mizokami M, Orito E, Ohba K, Nakano T, Kato T, Kondo Y, Ding X, Ueda R, Sonoda S, Tajima K, Miura T, Hayami M: GB virus C/hepatitis G virus infection among Colombian native Indians. Am J Trop Med Hyg 1998, 59: 462-467.
[48]	Berzsenyi MD, Bowden DS, Kelly HA, Watson KM, Mijch AM, Ham¬mond RA, et al. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology. 2007; 133(6): 1821-30.
[49]	El-Zayadi AR, Abe K, Selim O, Naito H, Hess G, Ahdy A: Prevalence of GBVC/ hepatitis G virus viraemia among blood donors, health care personnel, chronic non-B non-C hepatitis, chronic hepatitis C and hemodialysis patients in Egypt. J Virol Methods 1999, 80: 53-58.
[50]	Monica, V., Alvarado, M., Livia, B., Anna, N., Raymundo, A., Neto3, M. and Maria, F. (2011). Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection. Virol J. 8: 345.
[51]	Abu Odeh RO, Al‐Moslih MI, Al‐Jokhdar MW, Ezzeddine SA. Detection and genotyping of GBV‐C virus in the United Arab Emirates. J Med Virol 2005; 76: 534-40.
[52]	Akcali S, Sanlidag T, Ozbakkaloglu B. Prevalence of GBV-C/ hepatitis G virus viremia among chronic hepatitis B, chronic hepatitis C and hemodialysis patients in Turkey. Ann Saudi Med 2006; 26: 68-9.
[53]	Grassi M, Raffa S, Traditi F, Ferrazzi M, Cioschi S, Fontana M, et al. Detection and clinical evaluation of GBV-C/HGV in plasma from patients with chronic hepatitis of unknown etiology. Clin Ter. 2000 Jul-Aug; 151(4): 241-5.
[54]	Ramezani A, Gachkar L, Eslamifar A, et al. Detection of hepatitis G virus envelope protein E2 antibody in blood donors. Int J Infect Dis. 2008; 12: 57-61.